Literature DB >> 11112088

Liquid extraction and HPLC-DAD assay of hydrochlorothiazide from plasma for a bioequivalence study at the lowest therapeutic dose.

A Medvedovici1, C Mircioiu, V David, D S Miron.   

Abstract

The main parameters considered in optimizing the liquid extraction and quantitative assay were the yield, precision, limit of quantification, time required for extraction and concentration, and quantity of solvent. The influence on these parameters of the following factors was examined: nature of the extracting solvent, quantity of solvent, co-extraction solvent, and duration of stirring. Instead of equilibrium parameters of the involved thermodynamic system, a kinetic approach was preferred in terms of the effective partition 'constant', which is not really constant but a function of time and extraction conditions. The final selected method, considered to be rapid and simple, was applied to determine the pharmacokinetics of hydrochlorotiazide (HCT) after administration of Capozide (Bristol-Myers Squibb) tablets containing 50 mg Captopril and 25 mg HCT, to 4 healthy volunteers. The results obtained were in accordance with the pharmacokinetic parameters of HCT reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112088     DOI: 10.1007/BF03190073

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  16 in total

1.  A liquid chromatographic method for the determination of hydrochlorothiazide in human plasma.

Authors:  R B Miller; C Amestoy
Journal:  J Pharm Biomed Anal       Date:  1992-07       Impact factor: 3.935

2.  Column-switching high-performance liquid chromatographic (HPLC) determination of hydrochlorothiazide in rat, dog, and human plasma.

Authors:  B S Kuo; A Mandagere; D R Osborne; K K Hwang
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

3.  Simple and selective high-performance liquid chromatographic method for the determination of hydrochlorothiazide in urine.

Authors:  G K Shiu; V K Prasad; J Lin; W Worsley
Journal:  J Chromatogr       Date:  1986-04-25

4.  Column-switching techniques for screening of diuretics and probenecid in urine samples.

Authors:  P Campíns-Falcó; R Herráez-Hernández; A Sevillano-Cabeza
Journal:  Anal Chem       Date:  1994-01-15       Impact factor: 6.986

5.  High-performance liquid chromatographic determination of hydrochlorothiazide in plasma and urine.

Authors:  P P Koopmans; Y Tan; C A Van Ginneken; F W Gribnau
Journal:  J Chromatogr       Date:  1984-05-11

6.  Thiazides XI: partitioning of chlorothiazide in red blood cells after oral administration.

Authors:  V P Shah; M A Walker; J P Hunt; D Schuirmann; V K Prasad; B E Cabana
Journal:  Biopharm Drug Dispos       Date:  1984 Jan-Mar       Impact factor: 1.627

7.  Preliminary observations on dissolution and bioavailability of triamterene-hydrochlorothiazide combination products.

Authors:  V P Shah; M A Walker; V K Prasad; J Lin; G Knapp; B E Cabana
Journal:  Biopharm Drug Dispos       Date:  1984 Jan-Mar       Impact factor: 1.627

8.  Simple determination of hydrochlorothiazide in human plasma and urine by high performance liquid chromatography.

Authors:  J X de Vries; A Voss
Journal:  Biomed Chromatogr       Date:  1993 Jan-Feb       Impact factor: 1.902

9.  High-performance liquid chromatographic assay for hydrochlorothiazide in human urine.

Authors:  K B Alton; D Desrivieres; J E Patrick
Journal:  J Chromatogr       Date:  1986-01-10

10.  Optimization of selectivity in micellar chromatographic procedures for the determination of drugs in urine by direct injection.

Authors:  L J Love; J J Fett
Journal:  J Pharm Biomed Anal       Date:  1991       Impact factor: 3.935

View more
  1 in total

1.  Development of an HPLC-UV Method for the Analysis of Drugs Used for Combined Hypertension Therapy in Pharmaceutical Preparations and Human Plasma.

Authors:  Serife Evrim Kepekci Tekkeli
Journal:  J Anal Methods Chem       Date:  2013-03-24       Impact factor: 2.193

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.